We are delighted to announce that the TransBioLine Newsletter Year 3 is online!
This Newsletter summarizes the highlights of the scientific progress and the consortium activities during the third year of the project.
Don’t want to miss a thing about TransBioLine?
Subscribe to our newsletter now!
The TransBioLine project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821283. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA